Clinical Trial Update: Weight Gain Management in Patients With Schizophrenia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update from Eli Lilly on weight gain management in patients with schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Eli Lilly and Company | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED